English
Chinese (Simplified)
Portuguese
Spanish
German
Forward
Print
Comment
Women's Health Homepage
US Radiology Specialists partners with Touchstone Medical Imaging Contributes to US Radiology's 300 percent growth rate in less than a year
JLK Inspection unveils AIHuB Detects and monitors over 30 conditions in 14 body regions
Putting the patient at the center of breast care Insights from Agnes Berzsenyi, president and CEO of GE Healthcare Women’s Health
GammaPod stereotactic radiotherapy treatments underway in Maryland Aims to reduce costs and treatment sessions
Digital mammo increases cancer detection with no change in recall rates UK study shows it 14 percent better at finding tumors
New technique could reduce dose exposure during 3D X-ray exams Weighing the potential value of ghost imaging
Beyond detection: How DBT utilization rates impact facility benchmarks New evidence suggests 3D mammo could be as beneficial to providers as it is to patients
Merit Medical Systems closes acquisition of Cianna Medical Deal worth $135 million with possible additional incentivized payments
Remembering Dr. Nancy Cappello A patient advocate and champion of breast density awareness has passed away, but not without leaving her mark on the world
Screenings reduce risk of breast cancer death by 47-60 percent: study New research confirms what most physicians have long believed
Molecular breast imaging finds cancers that mammograms don't: study
The retrospective study, published in the August issue of the American Journal of Roentgenology, examined data from the supplemental screening program at ProMedica Breast Care in Toledo, Ohio, from 2011 to 2014. After having a mammogram, 1,696 women with dense breast underwent supplementary screening with Gamma Medica’s LumaGEM MBI system, which uses the technetium-99m sestamibi radiopharmaceutical and employs a dual-head digital detector and a special collimator. This resulted in the detection of 13 malignancies, after the mammograms read negative for cancer.
THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR
Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.
“That’s a significant amount of extra cancers,” Dr. Robin Shermis, medical director at the ProMedica Breast Care Center and one of the study’s authors, told HCB News.
The lesion size ranged from .6 to 2.4 centimeters, with a mean of 1.1 centimeters. About 85 percent of the cancers were node negative, which means the prognosis was better.
“We found them early and they would have otherwise gone undetected by mammography,” Shermis said.
The study also found that the positive predictive value (PPV) for recall was 9.1 percent and the PPV for biopsy was 19.4 percent.
Shermis explained that patients at ProMedica Breast Care with a lifetime risk of at least 20 percent for developing breast cancer receive supplementary screening with MR, while patients with dense breast tissue are recommended to receive supplementary screening with MBI.
“MR is a great test, but it’s very expensive and insurance companies won’t pay for it unless you’re high risk,” Shermis said.
MBI delivers almost instantaneous results, he added.
“This new study in the AJR provides further evidence that women with dense breast tissue have more comfortable and less stressful alternatives to standardized secondary screening studies,” said Philip Croxford, chief executive officer of Gamma Medica, in a statement. “These recent clinical results suggest there is a real alternative to the risk of misdiagnosis and unnecessary biopsies.”
The study by ProMedica follows a study by the Mayo Clinic, published in the AJR last year, which found the addition of MBI to mammography increased the invasive breast cancer detection rate 363 percent, from 1.9 to 8.8 per 1,000 screens.
MBI uses 6 to 8 millicuries, about four times the dose from a digital mammogram, though Shermis said it’s possible to cut the dose in half by scanning for twice as long. While some breast cancer experts don’t recommend MBI for annual screening because of the higher dose, Shermis noted that it was important to weigh the risks with the benefit of detecting cancers earlier.
“Six thousand women, who know the benefits and risks, have yet to say ‘I don’t want it,’” Shermis said.
You Must Be Logged In To Post A CommentRegisterRegistration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now! |
|
